Phenanthrene

Phenanthrene

SCHEMBL27970728

c1cc2c3c(cccc3c1)CC2.c1ccc2c(c1)ccc1ccccc12

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.55
HSD17B10 Q99714 8/20 0.55
TSHR P16473 4/20 0.55
CYP2A6 P11509 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
HPGD P15428 7/20 0.52
CYP1A2 P05177 5/20 0.52
THRB P10828 1/20 0.52
CYP3A4 P08684 4/20 0.50
HPRT1 P00492 1/20 0.50
LMNA P02545 2/20 0.47
MEN1 O00255 2/20 0.47
GAA P10253 2/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 2/20 0.47
FYN P06241 2/20 0.47
ACHE P22303 2/20 0.47
AHR P35869 2/20 0.47
MAPT P10636 2/20 0.47
ERBB2 P04626 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acenaphthene SCHEMBL28444594 0.86 ALDH1A1 (0.50) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Pyrene SCHEMBL27829598 0.85 ALDH1A1 (0.61) ALDH1A1HSD17B10TSHRTDP1HPGD
Acenaphthene SCHEMBL27742370 0.85 TSHR (0.52) ALDH1A1HSD17B10TSHRCYP2A6HPGD
Acenaphthene SCHEMBL1162573 0.85 TSHR (0.57) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Acenaphthene SCHEMBL3416108 0.85 TSHR (0.57) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Acenaphthene SCHEMBL9017 0.85 TSHR (0.57) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Acenaphthene SCHEMBL28028969 0.85 TSHR (0.57) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Acenaphthene SCHEMBL29386207 0.85 TSHR (0.57) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Acenaphthene SCHEMBL598252 0.85 TSHR (0.57) ALDH1A1HSD17B10TSHRHPGDCYP1A2
Acenaphthene SCHEMBL28014572 0.84 ALDH1A1 (0.65) ALDH1A1HSD17B10TSHRCYP2A6TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108601788-A EIF 4A-inhibiting compounds and methods relating thereto 效应治疗股份有限公司 2018-09-28 CN disclosed
CN-104039753-B The compositions of phenylcycloalkyl methylamine derivative, synthesis and using method 雷维瓦药品公司 2016-09-14 CN disclosed
CN-105246486-A Neuroactive steroids and methods of use thereof SAGE THERAPEUTICS INC 2016-01-13 CN disclosed
CN-104039753-A Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives REVIVA PHARMACEUTICALS INC 2014-09-10 CN disclosed